For a deeper look at vascular and cardiometabolic risk, see our pages on Preventive Cardiology and Silent Heart Disease Detection, Metabolic Health and Longevity Medicine, and ApoB and Longevity
The Risks of Trying GLP-1 Microdosing Without Medical Guidance GLP-1 microdosing may be discussed as a lower-intensity option, but trying it without clinical oversight can increase risk
Americas poison centers GLP-1
Our Inflammation and Longevity Medicine hub and article on Inflammation, Brain Health, and Mental Wellbeing explain why inflammatory burden belongs in the cognitive-health conversation
Learn more about our editorial process
Reduced benefits: Using doses that are too low may limit benefit, while stopping or adjusting treatment without follow-up can interfere with long-term metabolic or health goals